142 related articles for article (PubMed ID: 12408443)
1. Use of Lactobacillus-GG in paediatric Crohn's disease.
Guandalini S
Dig Liver Dis; 2002 Sep; 34 Suppl 2():S63-5. PubMed ID: 12408443
[TBL] [Abstract][Full Text] [Related]
2. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study.
Gupta P; Andrew H; Kirschner BS; Guandalini S
J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):453-7. PubMed ID: 11045848
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus GG in inducing and maintaining remission of Crohn's disease.
Schultz M; Timmer A; Herfarth HH; Sartor RB; Vanderhoof JA; Rath HC
BMC Gastroenterol; 2004 Mar; 4():5. PubMed ID: 15113451
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.
Bousvaros A; Guandalini S; Baldassano RN; Botelho C; Evans J; Ferry GD; Goldin B; Hartigan L; Kugathasan S; Levy J; Murray KF; Oliva-Hemker M; Rosh JR; Tolia V; Zholudev A; Vanderhoof JA; Hibberd PL
Inflamm Bowel Dis; 2005 Sep; 11(9):833-9. PubMed ID: 16116318
[TBL] [Abstract][Full Text] [Related]
5. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.
Prantera C; Scribano ML; Falasco G; Andreoli A; Luzi C
Gut; 2002 Sep; 51(3):405-9. PubMed ID: 12171964
[TBL] [Abstract][Full Text] [Related]
6. Probiotics and Crohn's disease.
Prantera C; Scribano ML
Dig Liver Dis; 2002 Sep; 34 Suppl 2():S66-7. PubMed ID: 12408444
[TBL] [Abstract][Full Text] [Related]
7. Probiotics for maintenance of remission in Crohn's disease.
Rolfe VE; Fortun PJ; Hawkey CJ; Bath-Hextall F
Cochrane Database Syst Rev; 2006 Oct; (4):CD004826. PubMed ID: 17054217
[TBL] [Abstract][Full Text] [Related]
8. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG.
Malin M; Suomalainen H; Saxelin M; Isolauri E
Ann Nutr Metab; 1996; 40(3):137-45. PubMed ID: 8862696
[TBL] [Abstract][Full Text] [Related]
9. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection.
Van Gossum A; Dewit O; Louis E; de Hertogh G; Baert F; Fontaine F; DeVos M; Enslen M; Paintin M; Franchimont D
Inflamm Bowel Dis; 2007 Feb; 13(2):135-42. PubMed ID: 17206696
[TBL] [Abstract][Full Text] [Related]
10. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
Ganji-Arjenaki M; Rafieian-Kopaei M
J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
[TBL] [Abstract][Full Text] [Related]
11. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
[TBL] [Abstract][Full Text] [Related]
12. Probiotics and prebiotics in Crohn's disease therapies.
Lichtenstein L; Avni-Biron I; Ben-Bassat O
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
[TBL] [Abstract][Full Text] [Related]
13. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.
Marteau P; Lémann M; Seksik P; Laharie D; Colombel JF; Bouhnik Y; Cadiot G; Soulé JC; Bourreille A; Metman E; Lerebours E; Carbonnel F; Dupas JL; Veyrac M; Coffin B; Moreau J; Abitbol V; Blum-Sperisen S; Mary JY
Gut; 2006 Jun; 55(6):842-7. PubMed ID: 16377775
[TBL] [Abstract][Full Text] [Related]
14. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
Malchow HA
J Clin Gastroenterol; 1997 Dec; 25(4):653-8. PubMed ID: 9451682
[TBL] [Abstract][Full Text] [Related]
15. Probiotics for prevention and treatment of diarrhea.
Guandalini S
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
[TBL] [Abstract][Full Text] [Related]
16. Low dose naltrexone for induction of remission in Crohn's disease.
Segal D; Macdonald JK; Chande N
Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease.
Steed H; Macfarlane GT; Blackett KL; Bahrami B; Reynolds N; Walsh SV; Cummings JH; Macfarlane S
Aliment Pharmacol Ther; 2010 Oct; 32(7):872-83. PubMed ID: 20735782
[TBL] [Abstract][Full Text] [Related]
18. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial.
Bauserman M; Michail S
J Pediatr; 2005 Aug; 147(2):197-201. PubMed ID: 16126049
[TBL] [Abstract][Full Text] [Related]
19. Probiotics and the management of inflammatory bowel disease.
Fedorak RN; Madsen KL
Inflamm Bowel Dis; 2004 May; 10(3):286-99. PubMed ID: 15290926
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of probiotics in inflammatory bowel disease.
Cain AM; Karpa KD
Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]